Merck (MRK) FCF Margin (2009 - 2026)

Merck (MRK) has 18 years of FCF Margin data on file, last reported at 17.97% in Q1 2026.

• FCF Margin for Q1 2026 came in at 17.97%, up 1043.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 21.46% (down 519.0% YoY), and the FY2025 annual result was 19.01%, down 919.0% from the prior year.
• FCF Margin climbed to 17.97% in Q1 2026 per MRK's latest filing, from 11.12% in the prior quarter.
• Over five years, FCF Margin peaked at 51.08% in Q3 2024 and troughed at 5.08% in Q4 2023.
• A 5-year average of 21.23% and a median of 18.22% in 2023 frame the typical range for FCF Margin.
• The sharpest annual moves came in 2022 and 2023: FCF Margin soared 2227 bps in 2022, then tumbled 2880 bps in 2023.
• A 5-year view of FCF Margin shows it stood at 23.72% in 2022, then sank by 121 bps to 5.08% in 2023, then jumped by 417 bps to 16.08% in 2024, then sank by 31 bps to 11.12% in 2025, then surged by 62 bps to 17.97% in 2026.
• Business Quant data shows MRK's FCF Margin at 17.97% in Q1 2026, 11.12% in Q4 2025, and 39.56% in Q3 2025.